Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VBI Vaccines
Biotech
BeiGene, Brii and Ideaya ring in 2025 with deals
Ideaya wrote the biggest check, handing Jiangsu Hengrui Pharmaceuticals $75 million upfront for a DLL3-directed ADC outside of Greater China.
Nick Paul Taylor
Jan 2, 2025 8:30am
VBI Vaccines files for bankruptcy, seeks asset sale
Jul 30, 2024 10:56am
Brii pays VBI $15M for global rights to hepB program and more
Jul 6, 2023 6:00am
VBI Vaccines pares down pipeline, staff to focus on hepatitis B
Apr 4, 2023 10:56am
Agios replaces CEO after recent FDA nod—Chutes & Ladders
Jul 15, 2022 9:30am
